论文部分内容阅读
目的 探讨测定脑卒中患者血清中抗心磷脂抗体 (anticardiolipin antibody,ACA)的临床价值。方法 应用金标免疫斑点法测定 118例脑卒中患者血清中 ACA的阳性率 ,并与正常对照组比较。结果 118例脑卒中患者血清 ACA阳性率显著高于对照组 (P<0 .0 0 1) ,再发性脑卒中患者与首发性脑卒中患者血清 ACA阳性率比较差异有显著性 (P<0 .0 5 ) ,而中青年脑卒中患者与老年脑卒中患者血清中 ACA阳性率比较差异也有显著性 (P<0 .0 0 5 )。结论 测定脑卒中患者血清中 ACA对确定脑卒中病因、治疗及预防均有指导意义。金标免疫斑点法简便、准确、快捷 ,便于推广使用
Objective To investigate the clinical value of anticardiolipin antibody (ACA) in serum of stroke patients. Methods The gold immunoblot assay was used to determine the positive rate of ACA in 118 cases of stroke patients and compared with the normal control group. Results The positive rate of ACA in 118 stroke patients was significantly higher than that of the control group (P <0.01). The positive rate of ACA in patients with recurrent stroke and primary stroke was significantly different (P <0. .0 5). There was also a significant difference in the positive rate of ACA in serum between middle-aged and young stroke patients and senile patients with stroke (P <0.05). Conclusion The determination of ACA in serum of stroke patients is of guiding significance in determining the cause, treatment and prevention of stroke. Gold standard immune spot method is simple, accurate, fast, easy to promote the use